Dietary Supplement
Centrum
Centrum is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
2
50%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)
Trials by Status
completed250%
unknown125%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_2
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
NCT05536596
withdrawnphase_2
The Role of Antioxidant Supplementation in Keratoconus Patients
NCT02827747
completedphase_3
Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
NCT00309387
completedphase_1
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
NCT01531790
Clinical Trials (4)
Showing 4 of 4 trials
NCT05536596Phase 2
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
NCT02827747Phase 2
The Role of Antioxidant Supplementation in Keratoconus Patients
NCT00309387Phase 3
Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
NCT01531790Phase 1
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4